Category: Peptides

Retatrutide search interest continues to climb. Here is the 2026 picture: Phase 3 trials, FDA status, and the difference between research and an approved medication.

GHK-Cu is surging in peptide and skincare searches. Here is what copper-peptide research actually supports—and where the evidence is still thin.

BPC-157 remains one of the most searched research peptides. Here is what changed in 2026, including FDA review and a recruiting Phase 2 hamstring study.